Client

INVOKANA (canagliflozin)

Problem

How do you build consumer preference for a new Type 2 Diabetes drug in a crowded category?

Executions

Content Hub, Digital, In-Office, TV, Video

Website

Print

V107138 July 17 Label Update Choices Spread 4 Cb Diabetic Living Winter R1936 V07 Lores

Behavior Change Support Content Hub